Резултати
еНаука >
Резултати >
Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?
Назив ![]() | Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients? | Аутори: | Jelovac, Marina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Година: | 2023 | Публикација: | International Journal of Molecular Sciences International Journal of Molecular Sciences |
ISSN: | 1422-0067![]() ![]() |
Тип резултата: | Научни чланак | Колација: | vol. 24 br. 10 str. 8538-8538 | DOI: | 10.3390/ijms24108538 | WoS-ID: | 000997568100001 | Scopus-ID: | 2-s2.0-85160375526 | PMID: | 37239884 | PMCID: | PMC10217985 | URI: | https://imagine.imgge.bg.ac.rs/handle/123456789/1859 https://enauka.gov.rs/handle/123456789/743151 |
М-категорија: | 21M21 - Рад у врхунском међ. часопису |